These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9627936)

  • 21. Measles incidence before and after mass vaccination campaigns in Burkina Faso.
    Kambiré C; Konde MK; Yaméogo A; Tiendrébéogo SR; Ouédraogo RT; Otten MW; Cairns KL; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S80-5. PubMed ID: 12721896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.
    Gay NJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Infect; 1995 Aug; 115(1):139-56. PubMed ID: 7641827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles in Morocco: epidemiological profile and impact of vaccination strategy.
    Cheikh A; Ziani M; Cheikh Z; Barakat A; El Menzhi O; Braikat M; Benomar A; Cherrah Y; El Hassani A
    Adv Ther; 2015 Feb; 32(2):172-83. PubMed ID: 25732939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful control and impending elimination of measles in the Islamic Republic of Iran.
    Zahraei SM; Gouya MM; Azad TM; Soltanshahi R; Sabouri A; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S305-11. PubMed ID: 21666178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles.
    Desai S; Shane A; Lewis R
    CMAJ; 2012 Nov; 184(16):1811. PubMed ID: 22641680
    [No Abstract]   [Full Text] [Related]  

  • 28. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013.
    Hao L; Ma C; Wannemuehler KA; Su Q; An Z; Cairns L; Quick L; Rodewald L; Liu Y; He H; Xu Q; Ma Y; Yu W; Zhang N; Li L; Wang N; Luo H; Wang H; Gregory CJ
    Vaccine; 2016 Dec; 34(51):6545-6552. PubMed ID: 26876440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles surveillance. Measles in the Caribbean prior to the elimination campaign.
    Wkly Epidemiol Rec; 1991 Oct; 66(40):291-4. PubMed ID: 1721830
    [No Abstract]   [Full Text] [Related]  

  • 32. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EPI sentinel surveillance for Kwara, 1982-1987.
    Babaniyi O
    West Afr J Med; 1993; 12(4):218-22. PubMed ID: 8199064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life.
    Taylor WR; Mambu RK; ma-Disu M; Weinman JM
    Am J Epidemiol; 1988 Apr; 127(4):788-94. PubMed ID: 3354544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closer to the goal: efforts in measles elimination in Germany 2010.
    Siedler A; Mankertz A; Feil F; Ahlemeyer G; Hornig A; Kirchner M; Beyrer K; Dreesman J; Scharkus S; Marcic A; Reiter S; Matysiak-Klose D; Santibanez S; Krause G; Wichmann O
    J Infect Dis; 2011 Jul; 204 Suppl 1():S373-80. PubMed ID: 21666187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal vaccine schedules to maintain measles elimination with a two-dose routine policy.
    McKEE A; Shea K; Ferrari MJ
    Epidemiol Infect; 2017 Jan; 145(2):227-235. PubMed ID: 27760574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A measles epidemic controlled by immunisation.
    Mansoor O; Blakely T; Baker M; Tobias M; Bloomfield A
    N Z Med J; 1998 Dec; 111(1079):467-71. PubMed ID: 9972200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in measles mortality reduction in Ethiopia, 2002-2009.
    Mitiku K; Bedada T; Masresha BG; Kegne W; Nafo-Traoré F; Tesfaye N; Yigzaw A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S232-8. PubMed ID: 21666166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.